A detailed history of Black Rock Inc. transactions in Immutep LTD stock. As of the latest transaction made, Black Rock Inc. holds 749,460 shares of IMMP stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
749,460
Previous 646,228 15.97%
Holding current value
$1.41 Million
Previous $1.55 Million 12.65%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$2.11 - $2.89 $217,819 - $298,340
103,232 Added 15.97%
749,460 $1.75 Million
Q4 2023

Feb 13, 2024

BUY
$1.76 - $2.49 $1.14 Million - $1.61 Million
646,228 New
646,228 $1.55 Million
Q3 2022

Nov 14, 2022

SELL
$1.71 - $2.29 $26,771 - $35,852
-15,656 Reduced 2.94%
517,096 $807,000
Q2 2022

Aug 12, 2022

SELL
$1.96 - $3.09 $23,418 - $36,919
-11,948 Reduced 2.19%
532,752 $1.08 Million
Q1 2022

May 12, 2022

BUY
$2.3 - $3.61 $269,201 - $422,528
117,044 Added 27.37%
544,700 $1.49 Million
Q4 2021

Feb 10, 2022

BUY
$3.09 - $4.81 $1.32 Million - $2.06 Million
427,656 New
427,656 $1.4 Million

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $163M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.